Luís Lopes Madureira Silva Miguel
AuthID: R-000-9J6
11
TITLE: TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS PREVIOUSLY TREATED WITH DOCETAXEL IN PORTUGAL Full Text
AUTHORS: Silva Miguel, LS; Paquete, AT; Guerreiro, R; Fiorentino, F; Costa, J; Borges, M;
PUBLISHED: 2018, SOURCE: VALUE IN HEALTH, VOLUME: 21
AUTHORS: Silva Miguel, LS; Paquete, AT; Guerreiro, R; Fiorentino, F; Costa, J; Borges, M;
PUBLISHED: 2018, SOURCE: VALUE IN HEALTH, VOLUME: 21
INDEXED IN: 
WOS
WOS12
TITLE: Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients who are Unsuitable for Full-Dose Fludarabine-Based Therapy
AUTHORS: Paquete, AT; Miguel, LS; Becker, U; Pereira, C; Pinto, CG;
PUBLISHED: 2017, SOURCE: APPLIED HEALTH ECONOMICS AND HEALTH POLICY, VOLUME: 15, ISSUE: 4
AUTHORS: Paquete, AT; Miguel, LS; Becker, U; Pereira, C; Pinto, CG;
PUBLISHED: 2017, SOURCE: APPLIED HEALTH ECONOMICS AND HEALTH POLICY, VOLUME: 15, ISSUE: 4
13
TITLE: Cost Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal
AUTHORS: Miguel, LS; Lopes, FV; Pinheiro, B; Wang, JS; Xu, RF; Pellissier, J; Laires, PA;
PUBLISHED: 2017, SOURCE: VALUE IN HEALTH, VOLUME: 20, ISSUE: 8
AUTHORS: Miguel, LS; Lopes, FV; Pinheiro, B; Wang, JS; Xu, RF; Pellissier, J; Laires, PA;
PUBLISHED: 2017, SOURCE: VALUE IN HEALTH, VOLUME: 20, ISSUE: 8
14
TITLE: Clinical and economic consequences of using dabigatran or rivaroxaban in patients with non-valvular atrial fibrillation
AUTHORS: Luis Silva Miguel; Jorge Ferreira;
PUBLISHED: 2016, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 35, ISSUE: 3
AUTHORS: Luis Silva Miguel; Jorge Ferreira;
PUBLISHED: 2016, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 35, ISSUE: 3
INDEXED IN: WOS
WOS15
TITLE: Consequências clínicas e económicas da utilização de dabigatrano e de rivaroxabano em doentes com fibrilhação auricular não valvular
AUTHORS: Luís Silva Miguel; Jorge Ferreira;
PUBLISHED: 2016, SOURCE: Revista Portuguesa de Cardiologia, VOLUME: 35, ISSUE: 3
AUTHORS: Luís Silva Miguel; Jorge Ferreira;
PUBLISHED: 2016, SOURCE: Revista Portuguesa de Cardiologia, VOLUME: 35, ISSUE: 3
16
TITLE: COST-EFFECTIVENESS OF PEMBROLIZUMAB IN PATIENTS WITH ADVANCED MELANOMA PREVIOUSLY TREATED WITH IPILIMUMAB IN PORTUGAL
AUTHORS: Miguel, LS; Lopes, FV; Pinheiro, B; Wang, J; Xu, R; Pellissier, J; Laires, PA;
PUBLISHED: 2016, SOURCE: VALUE IN HEALTH, VOLUME: 19, ISSUE: 7
AUTHORS: Miguel, LS; Lopes, FV; Pinheiro, B; Wang, J; Xu, R; Pellissier, J; Laires, PA;
PUBLISHED: 2016, SOURCE: VALUE IN HEALTH, VOLUME: 19, ISSUE: 7
17
TITLE: COST-EFFECTIVENESS OF PEMBROLIZUMAB FOR ADVANCED MELANOMA TREATMENT IN PORTUGAL
AUTHORS: Miguel, LS; Lopes, FV; Pinheiro, B; Wang, J; Xu, R; Pellissier, J; Laires, PA;
PUBLISHED: 2016, SOURCE: VALUE IN HEALTH, VOLUME: 19, ISSUE: 7
AUTHORS: Miguel, LS; Lopes, FV; Pinheiro, B; Wang, J; Xu, R; Pellissier, J; Laires, PA;
PUBLISHED: 2016, SOURCE: VALUE IN HEALTH, VOLUME: 19, ISSUE: 7
18
TITLE: Comentário a estudo de custo‐efetividade de rivaroxabano para prevenção de acidente vascular cerebral em doentes com fibrilhação auricular em Portugal
AUTHORS: Luís Silva Miguel;
PUBLISHED: 2015, SOURCE: Revista Portuguesa de Cardiologia, VOLUME: 34, ISSUE: 11
AUTHORS: Luís Silva Miguel;
PUBLISHED: 2015, SOURCE: Revista Portuguesa de Cardiologia, VOLUME: 34, ISSUE: 11
19
TITLE: Comment on "Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting''
AUTHORS: Luis Silva Miguel;
PUBLISHED: 2015, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 34, ISSUE: 11
AUTHORS: Luis Silva Miguel;
PUBLISHED: 2015, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 34, ISSUE: 11
INDEXED IN: WOS
WOS20
TITLE: COST-UTILITY ANALYSIS OF DELAYED-RELEASE DIMETHYL FUMERATE FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN PORTUGAL Full Text
AUTHORS: Silva Miguel, LS; de Sa, J; Pinheiro, B; Acosta, C;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
AUTHORS: Silva Miguel, LS; de Sa, J; Pinheiro, B; Acosta, C;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
INDEXED IN: WOS
WOS